|(R)-1-(3-(3-氨基-6-(2-氟-5-异丙氧基苯基)吡嗪-2-甲酰胺基)吡啶-4-基)哌啶-3-羧酸|CsnPharm

CAS No.: 2041073-22-5

GNF4877 Catalog No. CSN24803

GNF4877 is a potent DYRK1A and GSK3β inhibitor with IC50s of 6 nM and 16 nM, respectively

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A), a member of an evolutionarily conserved family of protein kinases that belongs to the CMGC group of kinases, has been studied as a potential cancer therapeutic target for its role in the regulation of cell cycle progression by affecting both tumor suppressors and oncogenesJarhad DB, Mashelkar KK, Kim HR, Noh M, Jeong LS. Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. J Med Chem. 2018;61(22):9791–9810.https://pubmed.ncbi.nlm.nih.gov/29985601/. Glycogen synthase kinase 3 (GSK-3) plays an important role in the pathogenesis of numerous disorders, affecting the central nervous system (CNS) encompassing both neuroinflammation and neurodegenerative diseases. Glycogen synthase kinase 3 beta (GSK-3β) is one of the GSK-3 isomersGolpich M, Amini E, Hemmati F, et al. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Pharmacol Res. 2015;97:16–26. https://pubmed.ncbi.nlm.nih.gov/25829335/. GNF4877 is a potent DYRK1A and GSK3β inhibitor with IC50s of 6 nM and 16 nM, respectively. GNF4877 stimulates proliferation of reversibly immortalized mouse beta (R7T1) cells, with EC₅₀ (half-maximal effective concentration) of 0.66 μM. Mouse model of type 1 diabetes (T1D) treated with GNF4877 (oral, 50 mg/kg twice daily) showed dramatically improved glucose tolerance, increased insulin staining, proliferating β-cells, β-cell mass (∼1.5 fold), insulin content (∼2 fold), and improved oral glucose tolerance, compared to vehicle-treated groupShen W, Taylor B, Jin Q, et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nat Commun. 2015;6:8372. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639830/.

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 2.0222 mL
- 10.1109 mL
- 20.2217 mL
- 5 mM
- 0.4044 mL
- 2.0222 mL
- 4.0443 mL
- 10 mM
- 0.2022 mL
- 1.0111 mL
- 2.0222 mL

技术信息

CAS号

2041073-22-5

储存条件

粉末: Sealed in dry,2-8°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C25H27FN6O4

运输

蓝冰

分子量

494.52

别名

溶解度

DMSO	4.0 mg/mL (8.1 mM)

动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

GNF4877 Catalog No. CSN24803

靶点选择性

请登录您的专属账户

确认信息